Dilution of Share Value from the Exercise of Stock Acquisition Rights
First written in FY2016. 21 of 28 entries say "Worsened", first in FY2017-Q2. Latest entry: FY2025.
CrowdWorks moved to the "Worse" side of this theme in 2017, 4 years before the typical company in this theme (2021).
The whole theme swung hardest in 2017: 34 of 60 companies on the "Worse" side.
37 other companies' latest entry also says "Worsened".
- FY2025WorsenedAnnual report
「1 October 2024–30 September 2025 (Note) 42,400 15,795,959」
The number of shares increased by 42,400 during the fiscal year through the exercise of share acquisition rights, bringing total shares issued to 15,795,959. A further 25,500 shares have been issued by the filing date. - FY2025-H1WorsenedAnnual report
「39,200 15,792,759 (Note) Increase resulting from the exercise of share acquisition rights.」
The number of shares increased by 39,200 through the exercise of share acquisition rights between October 2024 and March 2025, bringing total shares issued to 15,792,759. The crystallisation of dilution is continuing. - FY2024WorsenedAnnual report
「As of 30 September 2024, the number of potential shares from share acquisition rights was 658,100, equivalent to 4.18% of the total 15,753,559 shares issued.」
Potential shares increased from 599,400, or 3.86%, at the end of the previous fiscal year to 658,100, or 4.18%, expanding dilution exposure. - FY2024-Q2WorsenedAnnual report
「1 January 2024–31 March 2024 (Note) 14,800 15,535,860 (Note) Increase resulting from the exercise of share acquisition rights.」
The number of shares increased by 14,800 during the second-quarter accounting period through the exercise of share acquisition rights, bringing total shares issued to 15,535,860. - FY2024-Q1WorsenedAnnual report
「1 October 2023–31 December 2023 (Note) 11,100 15,521,060 7,601 2,758,909 7,601 2,716,909 (Note) Increase resulting from the exercise of share acquisition rights.」
The number of shares increased by 11,100 in the first quarter through the exercise of share acquisition rights, bringing total shares issued to 15,521,060. The crystallisation of dilution is continuing. - FY2023MitigatedAnnual report
「As of 30 September 2023, the number of potential shares from share acquisition rights was 599,400, equivalent to 3.86% of the total 15,509,960 shares issued.」
The potential share ratio declined from 4.51% at the end of the previous fiscal year to 3.86%. However, the number of shares increased by 238,500 during the fiscal year through the exercise of share acquisition rights, and the crystallisation of dilution itself is continuing. - FY2023-Q3WorsenedAnnual report
「1 April 2023–30 June 2023 50,600 15,491,160」
The number of shares increased by 50,600 in the third quarter through the exercise of share acquisition rights, bringing total shares issued to 15,491,160. The crystallisation of dilution is continuing. - FY2023-Q2WorsenedAnnual report
「1 January 2023–31 March 2023 (Note) 132,100 15,440,560」
The number of shares increased by 132,100 through the exercise of share acquisition rights, bringing total shares issued to 15,440,560. The crystallisation of dilution is continuing. - FY2023-Q1WorsenedAnnual report
「Increase resulting from the exercise of stock acquisition rights.」
The number of shares increased by 37,000 during the quarter through the exercise of share acquisition rights, bringing total shares issued to 15,308,460. The crystallisation of dilution is continuing. - FY2022WorsenedAnnual report
「As of 30 September 2022, the number of potential shares from share acquisition rights was 688,800, equivalent to 4.51% of the total 15,271,460 shares issued.」
Potential shares increased from 402,800, or 2.64%, at the end of the previous fiscal year to 688,800, or 4.51%, expanding dilution exposure. - FY2022-Q3WorsenedAnnual report
「1 April 2022–30 June 2022 10,000 15,271,160」
The exercise of stock acquisition rights increased the number of shares by 10,000 during the quarter, bringing the total number of shares issued to 15,271,160. The potential dilution continues to become apparent. - FY2022-Q2WorsenedAnnual report
「1 January 2022–31 March 2022 2,800 15,261,160」
The exercise of stock acquisition rights increased the number of shares by 2,800 during the quarter, bringing the total number of shares issued to 15,261,160. The potential dilution continues to become apparent. - FY2022-Q1WorsenedAnnual report
「The increase resulted from the exercise of stock acquisition rights.」
The exercise of stock acquisition rights increased the number of shares by 3,200 from 1 October to 31 December 2021, bringing the total number of shares issued to 15,258,360. - FY2021MitigatedAnnual report
「As of 30 September 2021, the number of potential shares from stock acquisition rights was 402,800, equivalent to 2.64% of the total 15,255,160 shares issued.」
The number of potential shares decreased from 450,000, or 2.95%, at the end of the previous fiscal year to 402,800, or 2.64%, reducing dilution exposure. - FY2020MitigatedAnnual report
「As of 30 September 2020, the number of potential shares from stock acquisition rights was 450,000, equivalent to 2.95% of the total 15,225,160 shares issued.」
The number of potential shares decreased from 1,076,500, or 7.08%, at the end of the previous fiscal year to 450,000, or 2.95%. - FY2020-Q2WorsenedAnnual report
「The increase resulted from the exercise of stock acquisition rights.」
The exercise of stock acquisition rights increased the number of shares by 15,000 from January through March 2020, bringing the total number of shares issued to 15,225,160. - FY2019WorsenedAnnual report
「As of 30 September 2019, the number of potential shares from stock acquisition rights was 1,076,500, equivalent to 7.08% of the total 15,210,160 shares issued.」
The number of potential shares increased from 678,500, or 4.7%, at the end of the previous fiscal year to 1,076,500, or 7.08%, increasing dilution exposure. - FY2019-Q3WorsenedAnnual report
「During the cumulative third quarter of the current fiscal year, we issued 781,000 new shares following the exercise of stock acquisition rights, among other transactions.」
New share issuance during the cumulative third quarter of the current fiscal year reached 781,000 shares through the exercise of stock acquisition rights and other transactions, and the potential dilution progressed further than through the previous quarter. - FY2019-Q2WorsenedAnnual report
「During the cumulative second quarter of the current fiscal year, we issued 436,000 new shares following the exercise of stock acquisition rights, among other transactions.」
The exercise of stock acquisition rights and other transactions resulted in the issuance of 436,000 shares cumulatively during the quarter, and the potential dilution is becoming more apparent. - FY2019-Q1WorsenedAnnual report
「As of 31 January 2019, a cumulative 3,250 stock acquisition rights had been exercised and 325,000 shares had been delivered.」
The exercise of stock acquisition rights resulted in the delivery of 325,000 shares as of 31 January 2019, after the filing, and the dilution of equity value is progressing. - FY2018MitigatedAnnual report
「As of 30 September 2018, the number of potential shares from stock acquisition rights was 678,500, equivalent to 4.7% of the total 14,319,160 shares issued.」
The number of potential shares decreased from 1,459,500, or 10.8%, in the previous fiscal year to 678,500, or 4.7%. - FY2018-Q3WorsenedAnnual report
「During the cumulative third quarter of the current fiscal year, we issued 763,500 new shares through a third-party allotment and the exercise of stock acquisition rights, among other transactions.」
Through a third-party allotment and the exercise of stock acquisition rights, among other transactions, new share issuance during the cumulative third quarter of the current fiscal year reached 763,500 shares, and the number of shares outstanding continues to increase. - FY2018-Q2WorsenedAnnual report
「1 January 2018–31 March 2018 376,000 13,929,660」
The exercise of stock acquisition rights increased the number of shares by 376,000 during the quarter, bringing the total number of shares issued to 13,929,660. The potential dilution is becoming further apparent. - FY2017MitigatedAnnual report
「As of 30 September 2017, the number of potential shares from stock acquisition rights was 1,459,500, equivalent to 10.8% of the total 13,553,660 shares issued.」
The number of potential shares decreased from 2,727,000, or 20.9%, in the previous fiscal year to 1,459,500, or 10.8%. - FY2017-Q3WorsenedAnnual report
「During the cumulative third quarter of the current fiscal year, we issued 274,000 new shares following the exercise of stock acquisition rights.」
The issuance of new shares through the exercise of stock acquisition rights reached a cumulative 274,000 shares, and the potential dilution is becoming further apparent. - FY2017-Q2WorsenedAnnual report
「During the cumulative second quarter of the current fiscal year, we issued 200,000 new shares following the exercise of stock acquisition rights.」
The company issued 200,000 shares cumulatively during the quarter through the exercise of stock acquisition rights, and the potential dilution is becoming more apparent. - FY2017-Q1MaterialisedAnnual report
「During the cumulative first quarter of the current fiscal year, we issued 110,000 new shares following the exercise of stock acquisition rights.」
The exercise of stock acquisition rights resulted in the actual issuance of 110,000 shares, increasing the number of shares issued. - FY2016First statedAnnual report
「As of 30 September 2016, the number of potential shares from stock acquisition rights was 2,727,000, equivalent to 20.9% of the total 13,277,660 shares issued.」
The company specifically discloses the number of potential shares from stock acquisition rights and their ratio to the total number of shares issued.